Apimeds Pharmaceuticals US, Inc. (APUS)
NYSEAMERICAN: APUS · Real-Time Price · USD
1.410
+0.050 (3.68%)
May 29, 2026, 4:00 PM EDT - Market closed

APUS Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
2121----
Enterprise Value
-17.630000
Last Close Price
1.411.64----
PB Ratio
-0.13----
P/TBV Ratio
0.140.12----
Debt / Equity Ratio
0.010.00-0.508.37-0.96-1.68
Net Debt / Equity Ratio
0.060.03-0.49-4.51-0.95-0.96
Net Debt / EBITDA Ratio
-0.33-0.35-0.520.19-1.06-0.22
Net Debt / FCF Ratio
-0.62-0.46-0.910.23-1.51-0.28
Quick Ratio
0.170.340.003.330.0216.09
Current Ratio
0.901.310.013.420.0216.16
Return on Equity (ROE)
-29.28%-7.90%209.61%228.15%140.46%430.32%
Return on Assets (ROA)
-13.84%-14.51%-586.07%-349.07%-717.20%-592.15%
Return on Invested Capital (ROIC)
-14.37%-15.04%318.79%1005.98%2733.15%10276.10%
Return on Capital Employed (ROCE)
-15.09%-15.63%357.91%10069.20%840.99%-631.20%
Buyback Yield / Dilution
-29.09%-37.68%-71.89%-19.56%0.00%-
Total Shareholder Return
-29.09%-37.68%-71.89%-19.56%0.00%-
SEC Filings: 10-K · 10-Q